The significant modulation of tumor microenvironment characterized by the loss of SMA(+) CAFs and increased CD34(+) vasculature in PD901 treated CCA may profoundly affect oxygen supplies to the tumor cells. The gene discussed is CD34; the disease is cholangiocarcinoma.